01.25.2023
Therapeutics
$558,806.00
24 months
Evaluation of a Gut-Specific Antifibrotic Therapeutic in Pre-clinical Models of Crohn's Disease
This project aims to advance a preclinical anti-fibrosis candidate molecule to testing in larger animal models and may lead to further development of the drug candidate toward clinical testing.